Home » All » Stock Forecast » CytoMed Therapeutics Limited Ordinary Shares Forecast

CytoMed Therapeutics Limited Ordinary Shares Forecasts for Tomorrow, Week, Month and 5 Years

Updated: April 22 · 2026 at 07:03 UTC

From

• 0.00%Market Cap $12.07M · Technical analysis Neutral · Focus area Price + volatility

Forecast Summary

Timeframe	Predicted Price	Past	Historical	Insight
Tomorrow	$1.01 ▼ -0.69%	Yesterday	$1.02 ▲ +0.29%	Tomorrow's CytoMed Therapeutics Limited Ordinary Shares (GDTC) setup is anchored to $1.02 and targets $1.01 (-0.69%). The near-term read is downside; watch $1.05 / $0.9894 because daily realized volatility is about 3.57%.
Tomorrow's CytoMed Therapeutics Limited Ordinary Shares (GDTC) setup is anchored to $1.02 and targets $1.01 (-0.69%). The near-term read is downside; watch $1.05 / $0.9894 because daily realized volatility is about 3.57%.
Week	$0.9980 ▼ -2.16%	Last Week	$1.03 ▲ +0.91%	The 7-day CytoMed Therapeutics Limited Ordinary Shares model moves from $1.03 to $0.9980 (-2.16%). It gives downside momentum context for this stock, so breaks around $1.05 / $0.9894 matter more than a single tick.
The 7-day CytoMed Therapeutics Limited Ordinary Shares model moves from $1.03 to $0.9980 (-2.16%). It gives downside momentum context for this stock, so breaks around $1.05 / $0.9894 matter more than a single tick.
Month	$0.9732 ▼ -4.59%	Last Month	$1.04 ▲ +1.93%	The 1-month CytoMed Therapeutics Limited Ordinary Shares target is $0.9732 (-4.59%), compared with the live reference near $1.02. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
The 1-month CytoMed Therapeutics Limited Ordinary Shares target is $0.9732 (-4.59%), compared with the live reference near $1.02. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
Year	$0.9359 ▼ -8.24%	Last Year	$1.06 ▲ +3.46%	The 1-year CytoMed Therapeutics Limited Ordinary Shares scenario points to $0.9359 (-8.24%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
The 1-year CytoMed Therapeutics Limited Ordinary Shares scenario points to $0.9359 (-8.24%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
5 Years	$0.8486 ▼ -16.80%	5 Years Ago	$1.09 ▲ +7.06%	The 5-year CytoMed Therapeutics Limited Ordinary Shares view is $0.8486 (-16.80%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
The 5-year CytoMed Therapeutics Limited Ordinary Shares view is $0.8486 (-16.80%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.

Tomorrow$1.01▼ -0.69%

Yesterday$1.02▲ +0.29%

Tomorrow's CytoMed Therapeutics Limited Ordinary Shares (GDTC) setup is anchored to $1.02 and targets $1.01 (-0.69%). The near-term read is downside; watch $1.05 / $0.9894 because daily realized volatility is about 3.57%.

Week$0.9980▼ -2.16%

Last Week$1.03▲ +0.91%

The 7-day CytoMed Therapeutics Limited Ordinary Shares model moves from $1.03 to $0.9980 (-2.16%). It gives downside momentum context for this stock, so breaks around $1.05 / $0.9894 matter more than a single tick.

Month$0.9732▼ -4.59%

Last Month$1.04▲ +1.93%

The 1-month CytoMed Therapeutics Limited Ordinary Shares target is $0.9732 (-4.59%), compared with the live reference near $1.02. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.

Year$0.9359▼ -8.24%

Last Year$1.06▲ +3.46%

The 1-year CytoMed Therapeutics Limited Ordinary Shares scenario points to $0.9359 (-8.24%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.

5 Years$0.8486▼ -16.80%

5 Years Ago$1.09▲ +7.06%

The 5-year CytoMed Therapeutics Limited Ordinary Shares view is $0.8486 (-16.80%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.

Risk notice:This forecast is informational only, not financial advice; accuracy depends on volatility, liquidity, macro events, and other external factors.

Price Chart

HistoricalForecastBullishBearish

Technical Analysis

Bearish

Bullish

Neutral

Bearish

Key Indicators

Indicator	Value	Signal
Price	$1.02	Mid
Daily Change	0.00%	Mid
Volatility Cap	20.0%	Mid
Confidence	57%	Below
Data Source	nasdaq-screener	Mid

Historical Data

Current$1.02

Daily Change0.00%

Market Cap$12.07M

Sourcenasdaq-screener

Current	$1.02	Daily Change	0.00%
Market Cap	$12.07M	Source	nasdaq-screener

Support & Resistance Levels

$0.9894Support 1

$1.02Current

$1.05Resistance 1

Support and resistance are estimated from the trusted current price until deeper historical data is available.

Price Milestones

Key levels & historical context

Current$1.02Live reference price

Used as the anchor for generated forecast calculations.

Next Month$0.9732Model projection-4.59%

Directional scenario based on capped drift.

Forecast Accuracy

How our model has performed

57%

Directional

Generated market-data forecast

This page uses live catalog market data and conservative volatility caps. It is informational, not financial advice.

📊

Our algorithm is re-calibrated weekly using the latest price action, volatility regime, and indicator signals. Accuracy varies by timeframe — short-term momentum is more reliable than long-term projections.

Short term

57%

Direction confidence

Long term

Lower

Forecast uncertainty rises with horizon

Investment Scenarios

If you invest $1,000 in GDTC today

Bullish Scenario

$1.07

+5.00% from current

Target Price$1.07

ScenarioUpside momentum

Probability49%

Base Scenario

$0.9732

-4.59%

Target Price$0.9732

ScenarioCapped drift

Probability57%

Bearish Scenario

$0.9690

-5.00% from current

Target Price$0.9690

ScenarioVolatility drawdown

Probability43%

Basis: Scenario model combines current spot price, recent market direction, and conservative asset-class volatility caps.

Forecast Factors

Market Structure

Price structure reflects the latest momentum regime and support/resistance interaction.

Momentum Bearish · 40/100

24H drift-0.69%

7D drift-2.16%

30D drift-4.59%

Technical Signals

Signals combine RSI, MACD, and moving average stacks to estimate short-term direction.

Mixed — Watching · 50/100

RSIn/a

MACDn/a

MA stackn/a

Macro Context

Rates, dollar strength, and cross-asset risk appetite influence medium-term paths.

Risk-Off Caution · 35/100

1M outlook-4.59%

1Y outlook-8.24%

5Y outlook-16.80%

Frequently Asked Questions

Q What is the CytoMed Therapeutics Limited Ordinary Shares (GDTC) forecast for tomorrow?

Using the latest BeCoin market snapshot (April 22 · 2026 at 07:03 UTC), CytoMed Therapeutics Limited Ordinary Shares is projected near $1.01 versus the current reference around $1.02. That implies a modeled move of -0.69% over the next day, with realized prices still sensitive to intraday volatility.

Q What does the 7-day stock outlook suggest for GDTC?

The weekly CytoMed Therapeutics Limited Ordinary Shares model points to $0.9980, which maps to an expected drift of -2.16% from current conditions. This horizon reacts quickly to momentum shifts, so support/resistance breaks can change the path faster than long-term targets.

Q How should I read the CytoMed Therapeutics Limited Ordinary Shares 1-month and 1-year targets?

The CytoMed Therapeutics Limited Ordinary Shares 1-month target is $0.9732 (-4.59%), while the 1-year target is $0.9359 (-8.24%). The monthly view tracks prevailing trend pressure, and the yearly view reflects broader cycle assumptions shaped by price momentum, liquidity, and company-specific risk.

Q Why does the CytoMed Therapeutics Limited Ordinary Shares 5-year scenario differ from short-term rows?

The CytoMed Therapeutics Limited Ordinary Shares long-horizon scenario sits near $0.8486 with a modeled change of -16.80%. It compounds cycle-continuation assumptions over time, so it should be treated as a scenario envelope rather than a precise endpoint.

Q Where are GDTC support and resistance zones right now?

For CytoMed Therapeutics Limited Ordinary Shares, nearest resistance is around $0.9894, while nearest support is around $1.05. A clean break above resistance improves continuation odds, while repeated closes under support raise downside risk.

Q How fresh is the CytoMed Therapeutics Limited Ordinary Shares market snapshot?

The displayed stock snapshot is labeled April 22 · 2026 at 07:03 UTC; the latest observed session range is roughly n/a to n/a. These checkpoints are rebuilt from the market feed so the FAQ, milestones, and support/resistance context stay tied to the same data refresh.